Status: current, Defined. Date: 30-Sep 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2070981000168111 | Maxatan (rizatriptan 10 mg) orally disintegrating tablet, 3 tablets, blister pack (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2070991000168114 | Maxatan 10 mg orally disintegrating tablet, 3, blister pack | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Maxatan 10 mg orally disintegrating tablet, 3, blister pack | Is a | Maxatan 10 mg orally disintegrating tablet, 3 | true | Inferred relationship | Some | ||
| Maxatan 10 mg orally disintegrating tablet, 3, blister pack | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Maxatan 10 mg orally disintegrating tablet, 3, blister pack | has TPUU | Maxatan 10 mg orally disintegrating tablet | true | Inferred relationship | Some | 1 | |
| Maxatan 10 mg orally disintegrating tablet, 3, blister pack | has container type | blister pack | true | Inferred relationship | Some | ||
| Maxatan 10 mg orally disintegrating tablet, 3, blister pack | has TP | Maxatan | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Description inactivation indicator reference set
Containered trade product pack reference set
FHIR